论文部分内容阅读
目的研究分析阿托伐他汀对急性脑梗死患者血清内脂素的影响。方法选取2010年1月~2012年9月我院收治的急性脑梗死患者82例为研究对象,随机分为两组。对照组给予常规临床治疗,实验组在对照组基础上给予阿托伐他汀治疗,观察比较两组患者治疗后血清内脂素水平。结果实验组患者治疗后,其血清内脂素低于对照组,治疗效果优于对照组,组间比较,P<0.05,差异有统计学意义。结论采用阿托伐他汀对急性脑梗死患者进行治疗,能够降低血清内脂素水平,提高治疗效果。
Objective To study the effect of atorvastatin on serum visfatin in patients with acute cerebral infarction. Methods A total of 82 patients with acute cerebral infarction admitted to our hospital from January 2010 to September 2012 were selected as the research object and randomly divided into two groups. The control group was given routine clinical treatment. The experimental group was given atorvastatin on the basis of the control group. The levels of serum visfatin in the two groups were observed and compared. Results After treatment, the serum visfatin in the experimental group was lower than that in the control group, and the therapeutic effect was better than that in the control group. There was significant difference between the two groups (P <0.05). Conclusion Atorvastatin treatment of patients with acute cerebral infarction, can reduce serum visfatin levels and improve the therapeutic effect.